Organization of haemopoietic stem cells: the generation-age hypothesis.
This paper proposes that the previous division history of each stem cell is one determinant of the functional organization of the haemopoietic stem cell population. Stem cells from a lineage of stem cells which have generated many stem cells (older stem cells) are used in the animal to form blood before stem cells which have generated few stem cells (younger stem cells). The stem cell generating capacity of a lineage of stem cells is finite. After a given number of generations a stem cell is lost to the stem cell compartment by forming two committed precursors of the cell lines. Its part in blood formation is taken by the next oldest stem cell. We have called this proposal the generation-age hypothesis. Experimental evidence in support of the proposal is presented. We stripped away older stem cells from normal bone marrow and 13 day foetal liver with phase-specific drugs and revealed a younger population of stem cells whose capacity for stem cell generation was three- to four-fold greater than that of the average normal, untreated population. We aged normal stem cells by continuous irradiation and serial retransplantation and found that their stem cell generative capacity had declined eight-fold. We measured the stem cell generative capacity of stem cells in the bloodstream. It was a half to a quarter that of normal bone marrow stem cells and we found a subpopulation of circulating stem cells whose capacity for stem cell generation was an eighth to a fortieth that of normal femoral stem cells. This subpopulation was identified by its failure to express the brain-associated antigen which was present on 75% of normal femoral stem cells but was not found on their progeny, the committed precursors of granulocytes.
D000818:Animals; D000941:Antigens / Q000032:analysis; D002455:Cell Division; D002470:Cell Survival; D002588:Cesium Radioisotopes; D003114:Colony-Forming Units Assay; D004731:Endotoxins / Q000494:pharmacology; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000276:immunology; D006918:Hydroxyurea / Q000494:pharmacology; D008297:Male; D051379:Mice; D010659:Phenylhydrazines / Q000494:pharmacology; D012485:Salmonella typhi; D014184:Transplantation, Homologous
D000941:Antigens; D002588:Cesium Radioisotopes; D004731:Endotoxins; D010659:Phenylhydrazines; D005472:Fluorouracil; D006918:Hydroxyurea